| Authors: |
Boulay E; Charles River, Laval, Canada; Faculty of Veterinary Medicine, University of Montreal, QC, Canada., Miraucourt LS; Charles River, Laval, Canada., Pugsley MK; Cytokinetics, South San Francisco, CA, USA., Abernathy MM; Lilly Corporate Center, Eli Lilly & Co, Indianapolis, IN, USA., Chui R; Cardiovascular Analytics, Newbury Park, CA, USA., Dalton J; Charles River, Mattawan, MI, USA., Demers M; Faculty of Veterinary Medicine, University of Montreal, QC, Canada., Dybdal N; Genentech, South San Francisco, CA, USA., Gazaille E; Faculty of Veterinary Medicine, University of Montreal, QC, Canada., Greiter-Wilke A; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Hoffmann P; Independent, Beaufort, SC, United States., Huang H; Charles River, Laval, Canada., LaDuke C; Novartis, East Hanover, NJ, USA., Norton K; Charles River, Senneville, QC, Canada., Pierson JB; HESI, Washington, DC, USA., Reeves I; Charles River, Laval, Canada., Roche B; Charles River, Ashland, OH, USA., Rossman EI; GlaxoSmithKline, Collegeville, PA, United States., Schultze AE; Lilly Corporate Center, Eli Lilly & Co, Indianapolis, IN, USA., Tang HM; RelayTx, Cambridge, MA, United States., Wisialowski T; Pfizer, Inc., Groton, CT, USA., Authier S; Charles River, Laval, Canada; Faculty of Veterinary Medicine, University of Montreal, QC, Canada. Electronic address: simon.authier@crl.com. |
